Anti-VEGF Market Size is projected to reach USD 13.54 Billion by 2030, growing at a CAGR of 1.02%: Straits Research
July 21, 2022 16:00 ET
|
Straits Research
New York, United States, July 21, 2022 (GLOBE NEWSWIRE) -- Vascular endothelial Growth factor, also known as VEGF, is a naturally occurring protein in the human body responsible for forming and...
UK National Screening Committee Report Singles Out Eyenuk’s EyeArt as the Only Diabetic Eye Screening AI Technology Ready for Live Clinical Implementation in the National Health Service
June 01, 2022 03:05 ET
|
Eyenuk, Inc.
LOS ANGELES, June 01, 2022 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...
Diabetic Retinopathy Pipeline Insights | Clinical Trials Evaluation Report 2022 by DelveInsight
May 30, 2022 13:00 ET
|
DelveInsight Business Research LLP
Las Vegas, USA, May 30, 2022 (GLOBE NEWSWIRE) -- Diabetic Retinopathy Pipeline Insights | Clinical Trials Evaluation Report 2022 by DelveInsight Diabetic Retinopathy Pipeline involves 80+ key...
Eyenuk Joins the Population Health Alliance, Paving Way for Autonomous AI to Improve Diabetes Complications
March 10, 2022 08:00 ET
|
Eyenuk, Inc.
WASHINGTON, March 10, 2022 (GLOBE NEWSWIRE) -- Population Health Alliance (PHA), the industry’s only multi-stakeholder professional and trade association solely focused on population health,...
Eyenuk Announces Publication of Strong EyeArt® Pivotal Clinical Trial Results in JAMA Network Open
November 15, 2021 14:38 ET
|
Eyenuk, Inc.
LOS ANGELES, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...
Eyenuk Applauds CMS CY 2022 Medicare Physician Fee Schedule Final Rule to Establish National Price for Autonomous AI Technology
November 04, 2021 17:09 ET
|
Eyenuk, Inc.
LOS ANGELES, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...
Eyenuk Reports Strong 2021 Business Growth
May 12, 2021 11:00 ET
|
Eyenuk, Inc.
LOS ANGELES, May 12, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...
National Coalition Launches new scEYEnce Campaign
September 09, 2020 09:00 ET
|
scEYEnce
—Effort points to the vital importance of vision research, how it is improving sight and broader health and well-being—NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- A national coalition of 10 leading...
ADM Tronics to Develop Patented, Next-Generation Ophthalmic Diagnostic System for RetinalGeniX Technologies, Inc.
January 13, 2020 09:54 ET
|
ADM Tronics Unlimited, Inc.
Northvale, NJ, Jan. 13, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- ADM Tronics Unlimited, Inc. (OTCQB: ADMT) announced that RetinalGeniX Technologies, Inc. (“RTI”), has entered into an engineering...
Retinal Disease Therapeutics Market to Reach US$ 21,318.0 Mn by 2026, Advancements in Retinal Disease Diagnosis Devices to Boost the Market, says Fortune Business Insights
July 12, 2019 06:44 ET
|
Fortune Business Insights
Pune, July 12, 2019 (GLOBE NEWSWIRE) -- The global Retinal Disease Therapeutics Market is likely to expand at an impressive rate driven by recent government participation towards prevention and...